Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Combined antitumor therapy with the chemotherapeutic drug doxorubicin and an anti-transferrin receptor immunotoxin: in vitro and in vivo studiesT W Griffin, M Stocl, J Collins, et al.Microbes and Infection|November 16, 2001
Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factorM A Marshall, D Jankovic, V E Maher, et al.International Immunology|August 1, 1997
Oncogenic mutations in ras create HLA-A2.1 binding peptides but affect their extracellular antigen processingM C Smith, C D Pendleton, V E Maher, et al.Cancer|March 15, 1993
Simultaneous chronic lymphocytic leukemia and chronic myelogenous leukemia. Evidence of a separate stem cell originV E Maher, L Gill, P L Townes, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Human antibody response to the intravenous and intraperitoneal administration of the F(ab')2 fragment of the OC125 murine monoclonal antibodyV E Maher, S J Drukman, R J Kinders, et al.Cytotherapy|May 25, 2002
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapyE C Wong, V E Maher, K Hines, et al.Clinical Pharmacology and Therapeutics|February 10, 2017
Association of time-varying clearance of nivolumab with disease dynamics and its implications on exposure response analysisC Liu, J Yu, H Li, et al.Leukemia & Lymphoma|June 28, 2001
The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphomaJ D White, G Wharfe, D M Stewart, et al.Pageof 1